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1. Introduction 
In 1885, Flemming reported the first morphological description of the natural process of cell 
death. This process is now known as apoptosis, a name that was chosen by Kerr [1] to 
describe the unique morphology associated with this type of cellular death, which is 
different from necrosis. After the initial description of apoptosis, it was recognized that this 
process occurs in all tissues as part of the normal cellular turnover. Apoptosis also occurs 
during embryogenesis, in which particular cells are ‘programmed’ to die, and hence the 
term ‘programmed cell death’ is used to describe this process. 
Currently, cell death can be classified according to the morphological appearance of the 
lethal process (apoptotic, necrotic, autophagic or associated with mitosis), the enzymological 
criteria (with or without the involvement of nucleases or distinct classes of proteases, such as 
caspases or cathepsins), the functional aspects (programmed or accidental, physiological or 
pathological) or the immunological characteristics (immunogenic or non-immunogenic) [2,3]. 
Apoptosis is a genetically predetermined mechanism that may be elicited through a number 
of molecular pathways, the best characterized and most prominent of which are called the 
extrinsic and intrinsic pathways (Fig.1). 
In the extrinsic pathway, which is also known as the “death receptor pathway”, apoptosis is 
triggered by the ligand-induced activation of death receptors at the cell surface, which 
include the tumor necrosis factor (TNF) receptor-1, CD95/Fas (the receptor of CD95L/FasL), 
and the TNF-related apoptosis inducing ligand receptors-1 and -2 (TRAIL-R1/2). In the 
intrinsic pathway, which is also called the “mitochondrial pathway”, apoptosis results from an 
intracellular cascade of events in which mitochondrial permeabilization plays a crucial role [4]. 
In vitro studies showed evidence that all animal cells constitutively express the proteins 
needed to undergo apoptosis [5,6]. Apoptosis is a process that involves a variety of signaling 
pathways that lead to multiple cellular changes throughout the cell death process [7,8]. 
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Figure 1. Extrinsic versus intrinsic caspase activation cascades. Left: extrinsic pathway. The ligand-
induced activation of death receptors induces the assembly of the death-inducing signaling complex 
(DISC) on the cytoplasm side of the plasma membrane. This promotes the activation of caspase-8 (and 
possibly of caspase-10), which in turn is able to cleave effector caspase-3, -6, and -7. Caspase-8 can also 
proteolytically activate Bid, which promotes mitochondrial membrane permeabilization (MMP) and 
represents the main link between the extrinsic and intrinsic apoptotic pathways. The extrinsic pathway 
includes also the dependency receptors, which deliver a death signal in the absence of their ligands, 
through yet unidentified mediators. Right: intrinsic pathway. Several intracellular signals, including 
DNA damage and endoplasmic reticulum (ER) stress, converge on mitochondria to induce MMP, which 
causes the release of proapoptotic factors from the intermembrane space (IMS). Among these, 
cytochrome c (Cytc) induces the apoptosis protease-activating factor 1 (APAF-1) and ATP/dATP to 
assemble the apoptosome, a molecular platform which promotes the proteolytic maturation of caspase-
9. Active caspase-9, in turn, cleaves and activates the effector caspases, which finally lead to the 
apoptotic phenotype. DNA damage may signal also through the activation of caspase-2, which acts 
upstream mitochondria to favor MMP.  Kroemer G, Galluzzi L, Brenner C.  (2007). 
The process of apoptosis has been conserved throughout evolution. Because of its conserved 
and uniform nature [8], apoptosis is frequently defined mechanistically as a pathway of 
regulated cell death that involves the sequential activation of caspases [Cysteine ASPartate-
Specific ProteASEs], which are the major effectors of apoptosis [9]. Many caspases are 
present in healthy cells as catalytically dormant pro-enzymes [zymogens] that have very 
low enzymatic activity [10] but become activated at the onset of apoptosis through 
activation signals [11]. The proteolytic cascade in which one caspase can activate other 
caspases amplifies the apoptotic signaling pathway and thus leads to rapid cell death. 
However, not all caspases are required for apoptosis. In fact, the process generally requires 
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the activation of a limited subset of caspases; in particular, caspases-3, -6, and -7 are the 
“executioner” caspases and these mediate their effects through the cleavage of specific 
substrates in the cell [12]. Over the last 10 years, intense research has focused on the 
pathways that control caspase activation. Some of these pathways, such as the apoptosome 
and death receptor-mediated pathways and the signalosomes responsible for caspase 
activation, are well established, whereas others are less clearly defined [12-14]. 
Other proteases, such as granzymes and calpain, are also involved in the apoptotic signaling 
process, but in a much more cell type- and/or stimulus-specific manner. At least three 
distinct caspase-signaling pathways exist: one is activated through the ligand-dependent 
death receptor oligomerization, the second through mitochondrial permeabilization, which 
leads to the release of proapoptotic proteins from the mitochondrial intermembrane space 
[15], and the third through stress-mediated events that involve the endoplasmic reticulum 
[16,17]. These pathways can also interact to amplify weak apoptotic signals. Some studies 
about programmed cell death indicate that apoptosis may occur in the complete absence of 
caspases; these instances include when organelles, such as the mitochondria, endoplasmic 
reticulum or lysosomes, are damaged leading to an increased release of calcium, species of 
oxygen free radicals and effectors proteins [18-20]. 
Formation of the death-inducing signaling complex (DISC) or the apoptosome activates 
initiator and common effectors caspases that execute the apoptosis process; both of these 
types of caspases are found in the cytoplasm. However, there is now evidence that the two 
pathways are linked and that molecules from one pathway can influence the other [16-24]. 
In addition, another mechanism activates a parallel caspase-independent cell death pathway 
via single stranded DNA damage [25]. 
2. Apoptosis mechanisms and pathways 
Studies from the 1970s and 1980s have shown that apoptosis can be defined by specific 
morphological characteristics and is regulated by specific biochemical processes. Studies 
using the nematode Caenorhabditis elegans have contributed most of the current 
understanding of the apoptosis mechanisms [26,27]. The final phase of apoptosis is the 
activation of endonucleases, which leads to the fragmentation of DNA. Apoptosis is 
genetically predetermined and there are therefore genes that can promote or inhibit it [27]; 
these genes can respond to both normal and pathological stimuli.  
Individual genes have been associated with apoptosis in two ways: the genes either are 
expressed in cells undergoing apoptosis or modulate the effects of the process. Among 
these, the proto-oncogene c-myc triggers either cell proliferation or apoptosis. Under normal 
conditions, this gene programs the cell to grow; however, if this procedure is prevented due 
to the lack of growth factors or the presence of secondary oncogenes, the cell enters the 
death process. The expression of c-myc is required for this process most likely because c-
myc influences the delicate balance between the survival and death signaling pathways that 
are simultaneously activated by this factor [28].  
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The caspases are directly or indirectly responsible for the morphological and biochemical 
changes that characterize the process of apoptosis [29]. The machinery of cell death effectors 
that is managed by the family of caspases cleaves many vital proteins and proteolytically 
active enzymes, a process that contributes to the destruction of the cell. All caspases are 
initially synthesized as inactive zymogens that contain a prodomain that is formed by a p20 
large subunit and a p10 small subunit. The activation of this zymogen precursor is mediated 
by a series of cleavage events, especially for the executioner caspases, which first separate 
the large and small subunits and then remove the prodomain. The active enzyme is 
composed of a heterotetramer that is formed by two large and two small subunits [30].   
To date, 14 mammalian caspases have been identified. These can be subdivided into families 
based on their sequence homology and substrate specificity [31]. Caspases can be classified 
as: Caspase-1 (ICE), caspase-2 (ICH-l, Nedd-2), caspase-3 (CPP32, Apopain, Yama), caspase-
4 (ICH-2, TX, ICEre), caspase-5 (ICErel, TY), caspase-6 (Mch2), caspase-7 (ICE-LAP3, Mch3, 
CMH-1), caspase-8 (FLICE,Mch5, MACH), caspase-9 (Mch6, ICELAP6), caspase-10 (Mch4), 
caspase-11 (ICH-3), caspase-12, caspase-13 (ERICE) and caspase-14 (MICE) [6]. Currently, 11 
human caspases have been identified: caspase-1 through -10 and caspase-14 [9,32,33]. The 
protein initially named caspase-13 was later found to represent a bovine homologue of 
caspase-4 [34] and caspase-11 and -12 are murine enzymes that are most likely the 
homologues of the human caspase-4 and -5. However, only some of these caspases have 
been found to be involved in the process of apoptosis; these are caspase-2, caspase-3, 
caspase-6, caspase-7, caspase-8, caspase-9, caspase-10 and caspase-12 [35]. 
Caspases can also be classified as either initiators or effectors. The upstream (initiator) 
caspases, unlike the downstream (effector) caspases, have long prodomains with structural 
motifs (e.g., death effector domain, DED, or caspase recruitment domain, CARD) that 
associate with their specific activators [36]. Any apoptotic extracellular or intracellular signal 
is transduced by adapter proteins and transmitted to specific cysteine proteases called 
“initiator caspases”, which commit the cell to apoptosis. However, the activated caspases 
can be inhibited by endogenous inhibitors, such as IAPs (inhibitors of apoptosis). The 
commitment is followed by the “execution” of the cells through the sequential activation of the 
“executioner caspases” and the systematic disintegration of the cellular structure, which is 
followed by the disposal of the dead cells by phagocytosis. The adapter proteins include 
molecules that are homologous to the nematode protein CED-4, whereas initiator and 
executioner caspases are homologues of CED-3. Each of the initiator caspases and the 
respective adapter molecules, which are responsible for the oligomerization of the caspase to 
which it binds, define distinct pathways for apoptotic caspase activation and cell death [37]. 
The apoptotic signaling pathways that lead to zymogen processing can be subdivided into 
two major categories: cell surface or intracellular sensor-mediated. The former pathway is 
activated in response to extracellular signals, which indicate that the existence of the cell is 
no longer needed for the well-being of the organism. These cell surface sensor-mediated 
apoptotic signals are initiated by the binding of ligands to cell surface death-mediating 
receptors, which include the death receptor family [38].  
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During the past two decades, extensive work has been performed to elucidate the molecular 
mechanism of apoptosis. It is clear that apoptosis is induced by a range of stimuli that 
activate two major cell death signaling pathways: the intrinsic pathway, which is mainly 
controlled by the Bcl-2 protein family members, and the extrinsic pathway, which is 
activated by the death receptors of the tumor necrosis factor receptor superfamily. 
The extrinsic pathway is triggered by death receptor engagement, which initiates a signaling 
cascade that is mediated by the activation of caspase-8. Specifically, apoptosis is induced by 
the interaction of a death receptor, namely, Fas (APO-1, CD95), TNF receptor-1 (TNFR-1), 
DR-3 (TRAMP), DR-4 (TRAIL-R1) or DR-5 (TRAIL-R2), with its respective ligand [39]. These 
cell surface receptors, which are located on the cell membrane, are members of the TNFR 
family. The binding of a ligand to a death receptor cause its oligomerization, which results 
in its activation. The oligomerization of the receptors is followed by the binding of specific 
adapter proteins (FADD, TRADD) to the receptor complex, which results in the recruitment 
of the procaspase-8 and -10 to the receptor complex where the proenzymes become 
activated. Active caspase-8 and -10, in turn, active through effector caspase-3 the caspase 
cascade [35]. The best-characterized ligands and their corresponding death receptors include 
FasL/FasR, TNF-α/TNFR1, Apo3L/DR3, Apo2L/DR4 and Apo2L/DR5 [40-43]. Alternatively, 
an extrinsic pro-apoptotic signal can be dispatched by the so-called ‘dependence receptors’, 
including netrin receptors (e.g., UNC5A-D and deleted in colorectal carcinoma, DCC). These 
receptors induce apoptosis in the absence of the required stimulus (when unoccupied by a 
trophic ligand, or possibly when bound by a competing ‘antitrophin’), but block apoptosis 
following binding of their respective ligands [2,3].  
The intrinsic pathway is activated when various apoptotic stimuli trigger the release of 
cytochrome c from the mitochondria, which is independent of caspase-8 activation. This 
activation occurs through the formation of an “apoptosome”, which consists of cytochrome 
c, the apoptotic protease activating factor-1 (Apaf-1) and procaspase-9. The formation of the 
apoptosome is dependent on both the release of cytochrome c from the mitochondria and 
free ATP or dATP in the cell [42-45]. Together with ATP/dATP, cytochrome c binds to Apaf-
1, a cytosolic protein, and induces its oligomerization, which leads to the recruitment of an 
initiator caspase, procaspase-9, which undergoes a conformational change that results in 
caspase-9 activation. These proteins (adaptor proteins and procaspases) interact via their 
caspase recruitment domains (CARD). The apoptosome then recruits procaspase-3, which is 
subsequently cleaved, and therefore activated, by the active caspase-9 and then released to 
mediate apoptosis. This mechanism is caspase-dependent; however, a caspase-independent 
cell death (CICD) pathway also exists. In this mechanism, the apoptosis-induced factor (AIF) 
and endonuclease G (EndoG) are released from the mitochondria and relocate to the 
nucleus, where they mediate the large-scale fragmentation of DNA independently of 
caspases [46]. 
The mitochondrial outer membrane (MOM) permeabilization is considered the ‘‘point of no 
return’’ for apoptotic cell death and triggers the release of proteins that mediate cell death, 
such as cytochrome c, into the cytoplasm [46,47].  
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The intrinsic cell death signals generally converge within the cell at the MOM and result in 
the loss of mitochondrial membrane integrity and the subsequent activation of the 
downstream apoptotic pathways. The release of cytochrome c and others proteins from the 
mitochondria is tightly regulated by pro-apoptotic members of the Bcl-2 family, which are 
believed to act as ion and/or protein channels or possibly as regulators of such channels 
[14,15,19]. The anti-apoptotic members of this family protect the cells from apoptosis 
through the sequestration of pro-apoptotic proteins or by interfering with their activities 
[48-50].  
The DR (extrinsic) and mitochondrial (intrinsic) apoptosis pathways have been described in 
detail [51-57].  
The pathway that is utilized depends on the initial death signal, the cell type involved, and 
the balance between pro-apoptotic and anti-apoptotic signals [58]. In addition, the initiation 
of a specific pathway may exhibit cross-talk with another, which might result in the 
activation of a second pathway. Although there is a wide variety of physiological and 
pathological stimuli and conditions that can trigger apoptosis, not all cells will necessarily 
die in response to the same stimulus.  
Recent studies implicate the ER as a third sub-cellular compartment that can signal 
apoptosis via a signaling pathway that is called the ER-stress pathway [59]. Prolonged ER 
stress or the mobilization of intracellular Ca++ stores stimulates the cleavage and activation 
of pro-caspase-12 (in mice), which is localized in the ER membrane, by m calpain. Once 
activated, caspase-12 then activates executioner caspases to induce apoptosis. Studies have 
shown that prolonged ER stress can result in the activation of caspase-12, which initiates 
apoptosis [56,60]. 
Several caspase regulators have been discovered, including activators and inhibitors of these 
proteases [22]. Inhibitor of apoptosis proteins (IAPs) interfere with apoptosis by blocking 
caspase activity. Therefore, because of their inhibitory activity against the executioner 
caspases, IAPs may inhibit all caspase-dependent apoptosis. However, Smac/DIABLO, a 
mitochondrial protein released in the cytosol in response to an apoptotic stimulus, inhibits 
the anti-apoptotic function of several members of the IAP family, thereby de-repressing 
caspase activation [61].  
The intrinsic pathway is marked by a requirement for the involvement of mitochondria. 
Under the control of the BCL-2 family the mitochondria participate in apoptosis by releasing 
apoptogenic factors.  
The Bcl-2 family members can be divided into three subfamilies based on their structural 
and functional features [62]. The anti-apoptotic subfamily contains the Bcl-2, Bcl-XL, Bcl-w, 
Mcl-1, Bfl1/A-1, and Bcl-B proteins. The members of this subfamily suppress apoptosis and 
contain all four Bcl-2 homology (BH) domains. Some pro-apoptotic proteins, such as Bax, 
Bak, and Bok, contain BH  1-3 domains and are therefore termed ‘‘multidomain” whereas 
other pro-apoptotic proteins possess only BH3 domain and are thus referred to as ‘‘BH3-
only’’ proteins [63]. 
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The intrinsic pathway, which is also called the BCL-2-regulated or mitochondrial pathway 
(in reference to the role this organelle plays), is activated by various developmental cues or 
cytotoxic stimuli such as viral infection, DNA damage and growth factor deprivation, and is 
strictly controlled by the BCL-2 family of proteins [64]. This pathway predominantly leads 
to the activation of caspase-9 [65], although, at least in certain cell types, it can proceed in 
the absence of caspase-9 or its activator, the apoptotic protease-activating factor-1 (Apaf1) 
[11]. The extrinsic, or DR pathway, is triggered by the ligation of the so-called death 
receptors, such as Fas or TNF-R1, which contain an intracellular death domain that 
associates with adaptor proteins that can recruit and activate caspase-8 through their Fas-
associates death domains (FADD; also known as MORT1). This activation of caspase-8 
causes the subsequent activation of downstream caspases, such as caspase-3, -6 or -7, and 
does not necessarily involve the BCL-2 protein family [64,66]. 
3. Physiological cell death in the immune system 
In the immune system, the death of T and B lymphocytes induced by specific receptors may 
occur in the central and peripheral lymphoid compartments. Apoptosis is the most common 
form of cell death in the immune system [67].  
Apoptosis occurs in the primary lymphoid organs, such as the bone marrow, the liver and 
the thymus, and is used to eliminate useless precursor cells with non-rearranged, or 
aberrantly rearranged, non-functional receptors. Furthermore, apoptosis is essential for the 
deletion of autoreactive T cells in the thymus and is therefore crucial in the assurance of 
central self-tolerance [68,69].  
A similar apoptotic deletion mechanism operates in the T and B cells that are located in the 
peripheral lymphoid organs, such as the lymph nodes and the spleen. This cell deletion by 
apoptosis is another safeguard of the immune system to assure self-tolerance and to 
downregulate an excessive immune response. Lymphocytes that escape this process 
probably replenish the pool of cells that determine immunological memory [70-73]. 
4. Antigenic stimulation drives proliferation and death 
The immune system has, among other characteristics,  its specificity: the repertoire of T and 
B lymphocytes, initially built from randomly selected antibody and T cell receptor (TCR) 
variable region genes, is shaped by selection to cope, on the one hand, with the vast 
universe of antigens and, on the other hand, with the danger of autoimmunity [74]. Another 
distinctive feature is the control of homeostasis; after a clonal expansion phase, the antigen-
reactive lymphocytes must be deleted until the pool of lymphoid cells reaches its baseline 
level. This controlled cell death is achieved by a fine-tuned balance between 
growth/expansion and apoptotic death; in general, because the immune system produces 
more cells than it needs, the extra cells are eliminated by apoptosis [75].  
The thymocytes that do not express a functional TCR die due to the lack of survival signals, 
an event that is known as “death by neglect”. In contrast, thymocytes bearing a TCR that 
 Apoptosis 80 
recognizes self-peptides that are presented by major histocompatibility complex (MHC) 
molecules are eliminated by apoptosis in response to a high-affinity signal; this process is 
termed negative selection [76,77]. Moreover, the normal immune response requires the 
regulated elimination of specific cell populations by apoptosis. During the development of T 
cells in the thymus and B cells in the bone marrow, all potentially autoreactive lymphocytes 
are removed by apoptosis. Therefore, the initial overproduction is followed by the death of 
those cells that fail to exhibit productive antigen specificities [49]. In addition, after the 
inciting antigen in an immune response has been cleared, cell death mechanisms return the 
number of lymphocytes to its normal physiological range.  
Only those lymphocytes bearing an antigen receptor with an appropriate specificity are 
selected for survival and further differentiation; the remaining (~75% and ~95% of B-cell and 
T-cell precursors, respectively) undergo apoptosis [78-81].  
The immature precursor T lymphocytes develop into mature antigen-reactive T cells in the 
thymus. The maturation process is associated with the acquisition of high expression levels 
of the TCR-CD3 complex and with tolerance to self antigens; these two characteristics are 
the consequence of positive and negative selection, respectively. Positive selection ensures 
the survival of immature T cells (CD4+CD8+) that have an appropriate TCR [53,82]. 
The number of T cells that leave the thymus and enter the peripheral T-cell pool is 
approximately 2–3% of the number of cells that were initially generated. The pre-T 
lymphocytes in the thymus undergo differentiation and TCR rearrangement. Those T cells 
that fail to rearrange their TCR genes productively and thus cannot be stimulated by self-
MHC–peptide complexes die by neglect. In contrast, cells with autoreactive receptors are 
killed by activation-induced death [83].  
Those thymocytes that successfully pass the pre-TCR selection develop into CD4+CD8+ T 
cells and undergo further TCR-affinity-driven positive and negative selection. After these 
selection processes, the mature single-positive CD4+ MHC class-II restricted and CD8+ 
MHC class-I-restricted T cells leave the thymus and generate the peripheral T-cell pool [52].  
There exists evidence for the positive selection of B cells based on B cell antigen receptor 
[BCR] specificity but the nature of the selecting ligands is not yet known. The processes of 
antigen receptor gene rearrangement and diversification can produce self-antigen specific B 
and T lymphoid cells that could initiate autoimmune tissue destruction [11]. 
Apoptosis also occurs as a defense mechanism in immune reactions or when cells are 
damaged by disease or noxious agents [84]. During infection, the lymphocytes and other 
cells of the innate immune system, which express receptors that recognize foreign antigens, 
undergo proliferation and differentiation to develop effectors functions that help kill the 
invading pathogens. These effectors functions, which include cellular- or antibody-mediated 
cytotoxicity and inflammatory cytokines, can be harmful to the host. Therefore, to limit the 
damage to healthy tissue, mechanisms, such as cell inactivation and cell death, have evolved 
to shut down these immune responses [85].  
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5. Activation-induced cell death 
The term “activation-induced cell death” (AICD) describes the signal-induced programmed 
cell death of T lymphocytes [86] and distinguishes this phenomenon, or apoptosis process, 
from other possible effects of antigen receptor ligation (e.g., cytokine production and clonal 
expansion). However, apoptosis via AICD is almost certainly a major mechanism of clonal 
deletion in the immune system.  
The AICD process is induced by the same signals that, in other circumstances, can lead to T 
cell proliferation and activation; these signals include antigen recognition, the binding of an 
antibody anti CD3 and the exposure to mitogens [87]. The AICD may occur in immature or 
transformed T cells, as well as in mature and activated peripheral blood T cells [88-94].  
The primary function of T lymphocytes is to mount an efficient immune response to an 
antigen. However, the maintenance of T lymphocyte homeostasis between antigenic 
challenges is also essential. Co-stimulatory molecules are required for efficient T cell 
responses and an IL-7 signal is essential for maintaining the homeostasis of both naïve and 
memory T cell populations. Both the intrinsic and the extrinsic apoptotic pathways are 
actively involved in the regulation of T cell responses and homeostasis. Several anti-
apoptotic molecules have been identified as critical effectors molecules in mature T 
lymphocytes and the co-stimulatory molecules signaling pathways [95].  
The proliferation and differentiation of T- and B-cells following antigen stimulation are 
crucial in the adaptive immune response. In fact, the activation of T cells is a critical step 
that occurs early in the adaptive immune response.  
The TCR is a transmembrane protein that consists of a heterodimer, which can be one of two 
types.  In 95% of T cells, the heterodimer consists of an alpha (α) and a beta (β) chain, which 
are expressed on the surface of T lymphocytes as part of a multi-subunit complex with the 
CD3 protein; in 5% of T cells, however, the heterodimer consists of gamma and delta (γ/δ) 
chains. When the TCR engages with the antigen that is presented on the MHC, the T 
lymphocyte is activated through a series of biochemical events that are mediated by a 
number of enzymes, co-receptors, accessory molecules, and activated or released 
transcription factors. The  chains of the TCR are joined by disulfide bonds and have a 
structure similar to immunoglobulins with an extracellular domain, which is responsible for 
the recognition of the antigenic peptide, a transmembrane domain and a short 
intracytoplasmatic domain [96,97].  
The induction of apoptosis via signaling through DR requires the close proximity of the 
intracytoplasmatic or transmembrane domain of several receptor molecules because their 
activation requires the cross-linking of several receptors [98-100].  
Antigen-presenting cells (APCs) are specialized white blood cells that help fight off foreign 
substances that enter the body. Enzymes inside the APCs break down the antigen into 
smaller particles. The processed antigens are transported to the surface of the APCs, bound 
with either an MHC class I or class II molecule. This complex forms epitopes (part of a 
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foreign substance that can be recognized by the immune system), which the TCR recognizes 
and binds to.   
Two signals derived from the APCs are required for  the activation-induced proliferation of 
T cells. The first signal is the engagement of the TCR to the MHC-antigen complex on the 
APC and the second involves the coupling of co-stimulatory molecules, such as CD28, on 
the T cell with the B7 protein family expressed by the APCs. The signaling pathways 
downstream of the TCR and CD28 involve the integration of complex signals that lead to 
activation, proliferation, cell survival, and death. These signals are all mediated by cell 
surface receptor-ligand interactions and cytokines, such as interleukin IL-2, IL-4, and IL-10, 
which are produced by accessory cells as well as the responding T cells themselves [101]. 
The CD3 protein complex, which is composed of five polypeptides ( , , , ), is non-
covalently associated with the TCR. Of the polypeptides, 90% the  chains form homodimers 
and 10% heterodimers with the  chains. The remaining three polypeptides associate to 
form the heterodimers  and , which are also transmembrane proteins with an 
intracytoplasmatic domain that is larger than the TCR αβ and is responsible for translating 
the activation signals through the complex to the inside of the cell [102]. The TCR, the ζ-
chain, and the CD3 molecules comprise the TCR complex. The in vitro stimulation of T cells 
with anti-CD3 antibody induces a signaling response that stimulates the activity of protein 
tyrosine kinase (PTK) within seconds [103]. The first event leads to a series of biochemical 
exchanges that occur over a period of many hours; these include the expression of cytokine 
receptors, the secretion of cytokines, the initiation of DNA replication and the acquisition of 
a differentiated phenotype [7,104]. 
The intracellular tails of the CD3 molecules contain a single conserved motif known as the 
immunoreceptor tyrosine-based activation motif (ITAM), which is essential for the signaling 
capability of the TCR. The PTK activity that is induced by the binding of a ligand to the TCR 
initiates the phosphorylation of tyrosine residues on a number of soluble and membrane-
associated substrates. The activation of the ITAMs causes it to act as the substrate for PTK 
and recruits this protein to the TCR [105,106]. 
TCR engagement by antigens triggers the tyrosine phosphorylation of the ITAMs, present in 
the TCR-CD3 complex. Such ITAMs function by orchestrating the sequential activation of 
the Src-related PTKs: Lck and Fyn, which initiate TCR signaling, followed by that of ZAP70, 
which further amplifies the response. Lck is activated by the interaction of MHC-II and CD4 
or CD8. These various PTKs induce tyrosine phosphorylation of several polypeptides, 
including the transmembrane adaptor  linker activator for T-Cells (LAT). Protein tyrosine 
phosphorylation subsequently leads to the activation of multiple pathways, including 
extracellular signal regulated kinase (ERK),  c-Jun N-terminal kinase (JNK),  nuclear factor 
kappa B and nuclear factor of activated T-Cells (NF-κB and NFAT) pathways, which 
ultimately induce effectors functions [105]. 
The AICD in peripheral T cells depends on the activation state of the cell, i.e., recently 
activated T cells are resistant to the induction of apoptosis and this initial resistance is 
followed by a subsequent sensitive phenotype.  
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The AICD occurs by either a suicidal or fratricidal mechanism through the activation, after 
TCR stimulation, of either Fas or TNF-R2, respectively. The importance of the Fas/FasL 
system for the activation of AICD was demonstrated by the discovery of a soluble receptor 
called decoy receptor 3 (DcR3) which is a member of TNFR superfamily. It has been shown 
to be the decoy receptor for FasL, which inhibits FasL-mediated apoptosis [75].  
Expression of FasL is restricted to the lymphoid organs, and defects in its expression are 
associated with pathophysiological and autoimmune disorders. The consequences of FasL 
shedding are quite substantial because only membrane-bound FasL (mFasL) triggers the 
death signal [106]. 
The TNF receptor family can also transduce signals via intermediary molecules that can 
lead, in some instances, to apoptosis via the activation of FADD and FLICE, which also 
mediate death signals from CD95 [54,108-112]. 
The first role described for the FADD protein was its interaction with the membrane-bound 
DRs, which leads to the hypothesis that it is cytoplasmic and only implicated in death 
signaling pathways. However, new evidence shows that FADD is a much more complex 
molecule. Depending on its phosphorylation state and subcellular localization, the FADD 
protein can induce apoptosis, survival, cell cycle progression or T cell proliferation [113].  
During development and maturation, lymphocytes with antigen receptors that are not 
properly rearranged, not positively selected or potentially self-reactive die by apoptosis. 
Similarly, immature cells that are not selected to enter the pool of mature circulating cells 
and peripheral cells that exert reactivity for self-antigens undergo apoptosis [92]. 
Several cells types are involved in the immune response. First, the B and T lymphocytes 
recognize antigen. After antigen binding to their antigen-specific receptors, these cells 
undergo clonal expansion and differentiation into effectors cells [114]. 
The developing lymphocytes express antigen receptors of random specificity. If, within a 
given window of time, the antigen receptors in the lymphocyte are ligated, the cell is 
deleted, which might occur through elimination or functional deletion by permanent 
unresponsiveness. If this ligation does not occur, the cell may mature and subsequently bind 
to the antigenic stimulus, thereby driving the immune response. The process of clonal 
deletion in the regulation of central tolerance is now well established [50]. The first 
unambiguous demonstrations of this process occurred with observations of negative 
selection, in which developing T lymphocytes in the thymus that expressed antigen 
receptors disappeared from the T-cell pool. 
The regulation of the life and death of T cells uses molecular mechanisms that may be 
different in distinct T-cell populations depending on their activation state [115].  
6. Dynamics of the immune response in peripheral lymphoid organs  
The induction of immunity occurs almost exclusively in the secondary lymphoid organs. 
Consequently, the examination of the lymphoid tissues allowed the elucidation of many of 
the steps that are involved in the generation of immunity. 
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In secondary lymphatic tissues, which are the primary locations for the generation of the 
humoral immune response, the coordinated trafficking of the immune cells is maintained 
through the direct interaction of the APCs with the T and B cells, which lead to the germinal 
center formation, the immunoglobulin class switching and the affinity maturation processes 
of the antibody response [116].  The antigens arrive at the lymph nodes by way of the lymph 
as soluble antigens, immune complexes or in association with dendritic cells (DCs). The 
systemic antigens and immune complexes reach the spleen and are first encountered by B 
cells, macrophages and DCs in the marginal zone (MZ). 
The site of B cell differentiation in response to antigen is the germinal center (GC). These 
structures, which arise within follicles, are responsible for the formation of long-lived 
memory via the long-lived circulating memory B cells and the long-lived plasma cells that 
typically reside in the bone marrow [117]. The GC has specific kinetics of expansion, 
contraction and ultimately dissolution. There is considerable proliferation and cell death 
within the GC, in addition to cell emigration from the GC [118]. 
In addition to soluble antigens transport into follicles, molecules smaller than 70–80 kDa are 
transported through the enclosed compartment of the reticular network, known as the 
conduit system, into the lumen of the high endothelial venules (HEV). The conduit system 
of the reticular network is a highly specialized extracellular matrix consisting of a central 
core, which is formed by interstitial matrix molecules, such as collagen type I and collagen 
type III. It is also surrounded by a basement membrane-like structure and is ensheathed by 
a layer of fibroblastic reticular cells [119]. 
The antigen presentation to B cells by DCs has been described by several groups and it is 
possible that outer T zone DCs present conduit-derived antigens to B cells. The conduits are 
also present within follicles but their contribution to antigen delivery within the follicles is 
not known. 
The deletion of B cells that recognize autoantigens occurs at both the immature B cell stage 
in the bone marrow and the mature B cell stage in the lymph nodes and the spleen. The 
critical events of B-cell activation, proliferation, differentiation and apoptosis occur in the 
GCs of the lymphoid follicles. A significant number of B cells die during passage through 
the GC and the apoptotic B cells are rapidly cleared from this area [120]. 
The B cells that arrive at the lymph nodes via HEV in the T-zone might encounter antigen-
bearing DCs during their migration. Alternatively, follicular B cells that migrate through the 
B–T boundary region during their random walk might engage the DCs that are concentrated 
in this region [117]. 
The production of clusters of antibody secreting cells (ASC) is an important initial 
component of the B cell response to antigen. It occurs during both T cell-dependent and T 
cell-independent responses [121]. Furthermore, it has been determined that, depending on 
the route of antigen delivery, different types of B cells may be involved in focus formation. 
For example, particulate antigens that are delivered through the blood will, upon entry into 
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the spleen, specifically activate MZ-B cells [122], whereas antigens that are delivered 
subcutaneously will activate follicular B cells through a complex process of antigen 
acquisition and B cell trafficking [123]. 
Apoptotic B cells are found throughout the GCs. Most of the apoptotic B cells, however, are 
located in the light zone, an area to which B cells from the dark zone immigrate. The dark 
zone is the site where most of the proliferation of germinal center B cells occurs [118]. Some 
of the dark zone B cells, termed centroblasts, express CD77 antigen. The CD77 molecule 
defines a B lymphocyte maturation pathway, specific for GC, where the cells undergo 
programmed cell death [124]. The apoptosis of germinal center B cells may be a consequence 
of a lack of stimulation through their cell surface Ig [125]. This lack of stimulation may lead 
to either affinity maturation, the process by which B cells produce antibodies with increased 
affinity for an antigen during an immune response, or to a decreased affinity for the 
immunizing antigen. Thus, B cells with functional receptors are positively selected and 
differentiate either towards B cell memory or plasma cells [126,127]. Within the lymphoid 
follicle, APO1/Fas are highly expressed in the areas where B-cell apoptosis occurs [128]. Bcl-
2 was shown to mediate an important survival signal for B cells and is believed to be 
involved in the maintenance of B-cell memory in GCs. The lack of Bcl-2 expression in areas 
where B cells die by apoptosis probably enables the cells to undergo apoptosis. On the other 
hand, overexpression of Bcl-2 in these cells would probably inhibit apoptosis [129,130]. 
There is evidence that the release of apoptogenic molecules from the mitochondria is not 
necessary for the induction of this pathway [131]. 
The CD40 receptor can mediate both pro- and anti-apoptotic signals. The binding of the 
CD40 ligand to its receptor can inhibit the apoptosis of B cells that are stimulated through 
their Ig receptors and can stimulate B cell proliferation and isotype switching. However, the 
same receptor-ligand interaction can also induce the expression of CD95 and therefore 
enhance the susceptibility of the B cell to CD95-mediated death [132].  
In peripheral T cells, the triggering of the TCR has several consequences: first, primary 
activation of resting T cells via the TCR may lead to proliferation of the T-cell population; 
second, in the absence of co-stimulatory signals, TCR triggering may cause anergy; and, 
finally, TCR triggering of previously activated T cells may lead to apoptosis unless the T 
cells are rescued by additional signals [133-135]. 
Whereas the activation of naïve T cells results in their clonal expansion and differentiation, 
the repeated stimulation of previously activated cells with antigen triggers AICD, which can 
be prevented by blocking the FasL/Fas interaction.  In addition, the AICD is associated with 
an activation-induced surface appearance of FasL, which, in turn, triggers death via Fas in 
an autocrine or paracrine fashion [53]. Therefore, most T cells become susceptible to the 
induction of apoptosis during their proliferation. This sensitization of T cells is achieved by 
the regulation of the extrinsic and the intrinsic apoptotic pathways and is influenced by T-
cell-associated IL-2 [136], which, in this context, acts as a sensitizer to AICD apoptosis rather 
than as a growth factor [137]. The molecular mechanism by which this T cell sensitization is 
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achieved involves the altered expression of genes that encode proteins such as BCL-2 family 
members, hematopoietic progenitor kinase 1 (HPK1), cellular FLICE-like inhibitory protein 
(cFLIP) family members and CD95L [138,139]. 
The AICD process involves the stimulation of CD95 [53,99,108], TNFR1 [139], TRAILR in 
‘helpless’ memory CD8 T cells [140-144]. Some findings suggest that TNF is involved in the 
late phase of AICD [41].  
In recent years, our research has focused on the development of a vaccine against 
Riphicephalus (Boophilus) microplus. Using the natural host as experimental model, the 
kinetics of the immune response in two peripheral lymphoid organs, the spleen and lymph 
nodes were studied. We performed a kinetic analysis of the apoptotic activity that occurs 
within the GCs of the draining lymph nodes of animals immunized with a synthetic vaccine 
after a primary and a secondary stimulation (Fig.2). The examination of the draining lymph 
nodes of the immunized bovines showed that the apoptosis in the GC occurred mainly in 
the dark zone seven days after immunization [146].  In parallel, we analyzed the in vitro 
immune memory and AICD of CD4+ T cells after stimulation with various inducers 
(mitramicina and cycloheximide) or inhibitors (benzimide riboside and cyclosporine A) and 
the synthetic vaccine. The AICD induced by the peptide was mediated by a calcineurin-
independent pathway. However, we observed the induction of cell death after stimulation 
of the TCR by the increased expression of Fas, which is characteristic of AICD.  
 
Figure 2. Microphotography of bovine lymph nodes. (A) TUNEL-positive cells in the dark zone of 
germinal center (GCs). (B) Arrow shows details of TUNEL-positive cells 7 days after immunization. 
Scale bar 50mm. 
7. Concluding remarks  
Much progress has been made over the past 15 years analyzing cell death in the immune 
system. Many cell death regulators have been discovered and their functions defined in 
experiments with transgenic and knockout mice. In the immune system, apoptosis is seen in 
cells that are stressed or deprived of growth factors, in developing cells that fail to properly 
rearrange an antigen receptor or express one that fails negative or positive selection, or in 
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cells that had expanded in response to an antigenic stimulus and are now in excess. We 
observed that the repeated stimulation of T cells previously activated with synthetic vaccine 
triggers AICD. Secondary lymphoid organs such as the spleen and lymph nodes provide the 
critical niches where naïve B cells encounter antigens and produce high-affinity antibodies. 
Many recent avenues of investigation have elucidated that the germinal center is a dynamic 
microenvironment where B-cells undergo repeated rounds of mutation and selection. The 
complex microarchitecture of the germinal center is therefore created not only by distinct 
stages of B-cell maturation but also by the distribution of immunophenotypically distinct 
and functionally specialized T, dendritic, and stromal cell subpopulations and their myriad 
interactions. The GC response is a complex process involving numerous cellular and cell 
surface components together with multiple signaling pathways. Recent advances in the field 
include a better understanding of the role of follicular dendritic cells, chemokines and TNF 
family members in forming and maintaining GC reactions. Even with these new advances, 
much remains to be understood in GC biology. Not only is there little understanding of the 
mechanisms that regulate and control GC B cell differentiation, but efforts need to be 
focused on examining abnormal GC responses, especially in the setting of autoimmunity 
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